Medical Necessity Under the Microscope: What a $6.73 Million DOJ Settlement Means for Procedural Practices

The Department of Justice recently announced that a California vascular practice and its owner physician agreed to pay more than $6.73 million to resolve allegations that medically unnecessary vascular procedures were performed on Medicare beneficiaries. While the settlement does not constitute an admission of liability, it offers an important reminder of a growing enforcement trend affecting procedural specialties across healthcare.

For years, many providers viewed False Claims Act investigations primarily through the lens of coding errors, billing irregularities, or kickback allegations. Today, federal enforcement agencies are increasingly focusing on a different question:

Was the procedure medically necessary in the first place?

For vascular specialists, interventional radiologists, cardiologists, pain management physicians, wound care providers, and ambulatory surgery centers, this shift has significant compliance implications.

The Allegations

According to the Department of Justice, the government alleged that from 2016 through 2024, Dr. Feliciano Serrano and his practice performed medically unnecessary dialysis access interventions and peripheral artery disease procedures on Medicare patients. The government alleged that procedures were repeated frequently despite limited clinical benefit, that stenosis severity was overstated in documentation, and that patient symptoms were documented in a manner designed to justify interventions.

Among the allegations highlighted by the DOJ:

• Repeated angioplasty and stent procedures on dialysis access patients.
• Peripheral artery interventions performed on patients with mild disease.
• Procedures performed on both legs despite symptoms being reported in only one leg.
• Documentation allegedly overstating clinical findings.
• Interventions repeated at unusually short intervals.

The settlement resolved allegations only, and no determination of liability was made. Nevertheless, the government’s message was unmistakable: providers who perform procedures outside accepted standards of medical practice may face substantial financial exposure under the False Claims Act.

A Broader Enforcement Pattern

This case is not occurring in isolation. Over the past two years, federal regulators have pursued several high-profile cases involving allegations of medically unnecessary procedures. Recent settlements have involved vein treatment services, wound care procedures, dialysis-related interventions, and other specialty services where medical necessity determinations play a central role. The pattern is becoming increasingly clear. Rather than focusing solely on whether a service was billed correctly, investigators are asking whether the service should have been performed at all.

That distinction dramatically changes the compliance landscape. A claim may contain the correct CPT code, appropriate modifiers, and accurate billing information yet still create False Claims Act exposure if regulators conclude the procedure lacked sufficient medical justification.

Why Procedural Specialties Face Elevated Risk

Procedural medicine naturally attracts scrutiny because interventions generate higher reimbursement than conservative management. Government investigators frequently examine situations involving:

• High procedure volume compared with peers.
• Repeat interventions performed at short intervals.
• Aggressive treatment of mild disease.
• Limited documentation of conservative therapy.
• Identical treatment patterns across large patient populations.
• Medical records containing similar or repetitive clinical narratives.

None of these factors automatically indicate wrongdoing. However, they often serve as initial audit triggers that prompt further review. In today’s enforcement environment, utilization data frequently becomes the starting point for an investigation.

Documentation Alone Is No Longer Enough

Many providers assume that thorough documentation automatically protects against enforcement risk. Increasingly, regulators are looking beyond documentation volume and focusing on documentation credibility. The Serrano case illustrates this point. Government allegations centered not only on the procedures themselves but also on whether clinical findings and patient symptoms accurately reflected medical reality.

As a result, compliance programs should evaluate not only whether records are complete but also whether they consistently support clinical decision-making. The strongest defense is documentation that clearly demonstrates:

• Patient-specific symptoms.
• Objective diagnostic findings.
• Failure of conservative treatment when applicable.
• Clinical rationale for intervention.
• Expected benefit of the procedure.
• Ongoing assessment of outcomes.

What Practices Should Do Now

This case provides several practical lessons for procedural organizations.

Review utilization patterns: Providers should periodically compare procedure frequency, repeat intervention rates, and treatment patterns against specialty benchmarks.

Audit medical necessity: Internal audits should evaluate clinical appropriateness, not merely coding accuracy.

Monitor repeat procedures: Repeated interventions within short timeframes deserve heightened review and documentation support.

Strengthen physician education: Many enforcement actions begin with clinical decisions rather than billing mistakes. Physicians should remain current on specialty society guidelines and payer medical necessity requirements.

Examine high-risk service lines: Peripheral vascular interventions, wound care, pain procedures, dialysis access management, and vein treatments continue to attract regulatory attention.

The Bigger Compliance Message

The most important takeaway from this settlement is not the dollar amount. It is the government’s continued focus on the intersection of utilization, documentation, and medical necessity. Historically, many compliance programs concentrated on coding audits and billing accuracy. While those remain important, federal enforcement increasingly evaluates whether services align with accepted standards of care and whether clinical documentation genuinely supports the interventions performed.

For healthcare organizations, the question is no longer simply, “Was the claim billed correctly?” The more important question may be: “Can we clearly demonstrate why this procedure was necessary for this patient at this time?”

Practices that can confidently answer that question will be better positioned to withstand audits, payer reviews, and potential government scrutiny in an increasingly aggressive enforcement environment.

Sources

1. U.S. Department of Justice. “Vascular Practice and Physician Agree to Pay More Than $6.73M to Settle False Claims Act Allegations of Unnecessary Vascular Interventional Procedures” (May 6, 2026).
2. HHS Office of Inspector General. Enforcement Action Summary (May 2026).
3. U.S. Department of Justice. “Health Care Management Corporation Agrees to Pay $4 Million to Resolve False Claims Act Allegations” (March 2026).
4. U.S. Department of Justice. “Vohra Wound Physicians and its Owner Agree to Pay $45M to Settle Fraud Allegations” (November 2025).
5. U.S. Department of Justice. “Vascular Access Centers to Pay at Least $3.825 Million to Resolve False Claims Act Allegations” (2018).